MERK

Merck Tbk.

3.750

09 Oct 2026

PER

5,05

PBV

1,72

ROE

34,15%

Current Ratio

4,26

DER

30,39%

Berdasarkan data Trailing Twelve Months (TTM).

Klasifikasi

Sektor Kesehatan
Industri Farmasi
Sub Industri Farmasi
Business Line —
Product & Commodity —

Info Umum

Tanggal Pencatatan —
Mata Uang IDR
Email —
Telepon —
Alamat Jl. TB Simatupang No. 8 - Pasar Rebo, Jakarta Timur

Tentang Perusahaan

PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing, and marketing pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders comprising hyperthyroidism and hypothyroidism. In addition, it leases and manages properties. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.